Evaluation of the possibility of Reversion of virulence and Safety tests of Razi Institute ‘s live attenuated Fowl Pox vaccine

Document Type : Full Research Paper

Authors

1 Department of Quality control, Razi Vaccine and Serum Research institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran

2 Department of Research and Production of Poultry Viral Vaccine, Razi Vaccine and Serum Research institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran

3 , Department of Research and Production of Poultry Viral Vaccine, Razi Vaccine and Serum Research institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran

4 Department of Poultry Disease Diagnosis, Razi Vaccine and Serum Research institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran

5 Department of Avian Diseases Research and Diagnostic, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran

Abstract

Vaccination is an important tool in controlling many diseases in the poultry industry. Today, a variety of vaccines, including live attenuated, killed and recombinant, etc. are produced against poultry pathogens. Despite the introduction of new generation vaccines, classical vaccines, including live attenuated vaccines, still retain their status and importance and are widely used. Vaccines containing the attenuated virus are prepared from mutant viruses whose antigenic properties are similar to those of the wild-type virus but are not able to cause all stages of pathogenicity in the host, including the problems and harms of such vaccines. The reversion to virulence in the vaccine may probably occur during viral replication in host. In this study, a reversion to virulence and safety tests was performed on Fowlpox vaccine seeds produced by Razi Institute. In order to perform the test vaccine seeds provided by the research and production of poultry vaccines, at least 5 consecutive passages of the virus were performed in SPF chickens and then the safety test of the vaccine was performed. The results of the tests showed that the vaccine virus produced by Razi Institute comply with BP and OIE specifications.

Keywords


1.Apple M.J.G.1978.Reversion to Virulence of Attenuated Canine Distemper Virus In Vivo and In Vitro. Journal of General Virology 41(2):385-390.
2.Atkinson, C., K.C. Wiegand, D. Triglia, and S.I. Jarvi. 2012. Reversion to virulence and efficacy of an attenuated Canarypox vaccine in Hawai'i 'Amakihi (Hemignathus virens). Journal of Zoo and Wildlife Medicine 43(4):808-819.
3.European Medicine agency.2021. Vectormune FP ILT (fowlpox and avian infectious Laryngotracheitis vaccine (live, recombinant))https://www.ema.europa.eu/en/documents/overview/vectormune-fp-ilt-epar-medicine-overview_en.pdf.Accession date :26/11/2021.
4.European Pharmacopeia 9.0.2016. https://www.edqm.eu/sites/default/files/index_9th_edition_pheur.pdf. 1064.
5.Gilhare, V.R, S.D. Hirpurkar, A. Kumar, S.K. Naik and T. Sahu. 2015. Pock forming ability of fowl pox virus isolated from layer chicken and its adaptation in chicken embryo fibroblast cell culture. Veterinary  World 8(3):245-50.
6.Gholami-Ahangaran, M., N. Zia-Jahromi and A. Namjoo. 2014. Molecular detection of avian pox virus from nodular skin and mucosal fibrinonecrotic lesions of Iranian backyard poultry. Tropical Animal Health and Production 46(2): 349-353.
7.Hanly,K.A.2011.The double-edged sword: How evolution can make or break a live-attenuated virus vaccine. Evulotion 4(4):635-643
8.Hopkins S.R and H.W. Yoder.1985. Reversion to Virulence of Chicken-Passaged Infectious Bronchitis Vaccine Virus. Avian Diseases 30(1):221-223.
9.Nayeri Fasaei, B., O. Madadgar, A. Ghalyanchi Langeroodi and M.M. Ghafari. 2014. Molecular detection and phylogenetic analysis of Avipoxvirus strains isolated from different bird species. Iranian Journal of Veterinary Research 15: 40-44.
10.Norouzian,  H. and G.h. Farjanikish .2016. Pathological and molecular diagnosis of avian pox in backyard chickens in Khorram Abad. Veterinary Researches & Biological Products. 117: 2-10. [ In Farsi]
11.OIE Manual of Diagnostic Tests and Vaccines for Terrestrial.2016. Fowl Pox (Chapter 3.3.10). https://www.oie.int/en/what-we-do/standards/codes-and-manuals/terrestrial-manual-online-access/ accessed online at 30/03/2021
12.Okamoto, A.S., A. Menconi, Gonçalves G.A., T.S. Rocha, Andreatti F.R and E.N. Savano. 2010. Reversion to Virulence Evaluation of a 9R Vaccine Strain of Salmonella enterica Serovar Gallinarum in Commercial Brown Layers Brazilian Journal of Poultry Science 12(1):47-52.
13.Sharma, D. K. and S. N. Sharma. 1988. Comparative immunity of fowl pox virus vaccines. Journal of Veterinary Medicine 35:19–23.
14.Siccardi, F. J. 1975. The addition of fowlpox and pigeonpox vaccine to Marek’s vaccine in broiers. Avian Diseases 19:362–365.
15.Singh, G.K, N.P. Singh and S.K.C. Garg. 1987. Studies on pathogenesis of fowlpox: Virological study. Acta Virologica 31: 417-423.
16. Tripathy, D.N. and C.H. Cunningham. 2008. Avian pox. pp. 524-534.In: Hofitad, M.S., H. J.Barnes,  B. W.Calnek., Reid. W. M. and H. W. Yoder) eds.). Diseases of Poultry, 8th edition, Ames Iowa State University Press, USA.